SCHEMBL2856372

SCHEMBL2856372

O=C(O)C1CCCC(C(=O)O)C(C(=O)O)C1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PEPD P12955 1/20 0.48
MEN1 O00255 1/20 0.44
BLM P54132 1/20 0.44
KMT2A Q03164 1/20 0.44
ACE P12821 1/20 0.42
POLB P06746 2/20 0.42
KDM4E B2RXH2 2/20 0.42
APEX1 P27695 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GMNN O75496 1/20 0.42
LMNA P02545 1/20 0.42
PMP22 Q01453 1/20 0.42
TFPI2 P48307 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
GABRR1 P24046 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1297964 0.94 PEPD (0.48) PEPDMEN1BLMKMT2AACE
SCHEMBL8400202 0.88 KDM4E (0.44) PEPDMEN1BLMKMT2APOLB
SCHEMBL9782998 0.88 GABRR1 (0.50) MEN1KMT2APOLBKDM4EAPEX1
SCHEMBL722221 0.88 GABRR1 (0.50) MEN1KMT2APOLBKDM4EAPEX1
SCHEMBL2115874 0.87 PEPD (0.43) PEPDMEN1BLMKMT2AACE
SCHEMBL19656161 0.85 PEPD (0.42) PEPDMEN1BLMKMT2AACE
SCHEMBL419838 0.84 PEPD (0.61) PEPDMEN1BLMKMT2AACE
SCHEMBL152716 0.84 PEPD (0.61) PEPDMEN1BLMKMT2AACE
SCHEMBL1957322 0.84 PEPD (0.61) PEPDMEN1BLMKMT2AACE
SCHEMBL13523741 0.84 PEPD (0.61) PEPDMEN1BLMKMT2AACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101057178-B Liquid crystal aligning agent for vertical alignment, liquid crystal alignment film, and liquid crystal display element using the same NISSAN CHEMICAL IND LTD 2010-06-02 CN claimed
WO-2026100662-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2026-05-15 WO disclosed
CN-119856108-A Liquid crystal aligning agent and liquid crystal display element 日产化学株式会社 2025-04-18 CN disclosed
WO-2025033304-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-02-13 WO disclosed
CN-112292633-B Method for manufacturing zero-face anchor film and liquid crystal display element 日产化学株式会社 2024-11-19 CN disclosed
CN-112313571-B Method for manufacturing zero-face anchor film and liquid crystal display element 日产化学株式会社 2024-11-19 CN disclosed
CN-118829938-A Weak anchoring liquid crystal aligning agent and liquid crystal display element 日产化学株式会社 2024-10-22 CN disclosed
CN-118742847-A Weak anchoring liquid crystal aligning agent and liquid crystal display element 日产化学株式会社 2024-10-01 CN disclosed
CN-113272729-B Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element 日产化学株式会社 2024-08-20 CN disclosed
US-12034021-B2 Structure, composition for near-infrared cut filter, dry film, method for producing structure, optical sensor, and image display device FUJIFILM CORPORATION (JP) 2024-07-09 US disclosed
US-20070093667-A1 Heterogeneous catalyst and process for producing oxirane compound with the catalyst NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-04-26 US disclosed
US-7090900-B2 Liquid crystal aligning agent for vertical alignment, alignment layer for liquid crystal, and liquid crystal displays made by using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-08-15 US disclosed
EP-1632291-A1 HETEROGENEOUS CATALYST AND PROCESS FOR PRODUCING OXIRANE COMPOUND WITH THE CATALYST Nissan Chemical Industries, Ltd. (JP) 2006-03-08 EP disclosed
US-20050058780-A1 Liquid crystal aligning agent for vertical alignment, alignment layer for liquid crystal, and liquid crystal displays made by using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-03-17 US disclosed
CN-1585912-A Liquid crystal aligning agent for vertical alignment, alignment layer for liquid crystal, and liquid crystal displays made by using the same NISSAN CHEMICAL IND LTD (JP) 2005-02-23 CN disclosed
EP-1450203-A1 LIQUID CRYSTAL ALIGNING AGENT FOR VERTICAL ALIGNMENT, ALIGNMENT LAYER FOR LIQUID CRYSTAL, AND LIQUID CRYSTAL DISPLAYS MADE BY USING THE SAME Nissan Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed
US-20040062878-A1 Aligning agent for liquid crystal for in-plane switching, liquid-crystal alignment film, and liquid-crystal display element MANO YUICHI (JP) 2004-04-01 US disclosed
EP-1331510-A1 ALIGNING AGENT FOR LIQUID CRYSTAL FOR IN-PLANE SWITCHING, LIQUID-CRYSTAL ALIGNMENT FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT Nissan Chemical Industries, Ltd. (JP) 2003-07-30 EP disclosed
US-6294639-B1 ADHESIVE PROPERTIES AND THE PRINTING PROPERTIES TO A SUBSTRATE, WHICH IS FREE FROM SEPARATION FROM SUBSTRATE DURING RUBBING AND PROVIDES VOLTAGE HOLDING PROPERTY NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2001-09-25 US disclosed
EP-1037092-A1 LIQUID CRYSTAL ALIGNING AGENT Nissan Chemical Industries, Ltd. (JP) 2000-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093667-A1 Heterogeneous catalyst and process for producing oxirane compound with the catalyst OXGR1, OXER1, OGFOD1 PEPD 3817/4885MEN1 3099/4885BLM 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.